Cuba Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Humoral Immunity Study After Booster Vaccination of " Soberana Plus " (The Republic of Cuba) Against COVID-19
Condition: Humoral Immunity Intervention: Biological: Conjugate vaccine Soberana Plus S, technical name FINLAY-FR-1A, is a COVID-19 candidate vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. Sponsor: Gomel State Medical University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2023 Category: Research Source Type: clinical trials

Humoral Immunity Study After Booster Vaccination of Soberana Plus (Republic of Cuba) Against COVID-19
Condition: Humoral Immunity Intervention: Biological: Conjugate vaccine Soberana Plus S, technical name FINLAY-FR-1A, is a COVID-19 candidate vaccine produced by the Finlay Institute, a Cuban epidemiological research institute. Sponsor: Gomel State Medical University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2023 Category: Research Source Type: clinical trials

Tolerance to NeuroEPO in Parkinson Disease
Condition: Parkinson Disease Intervention: Drug: NeuroEPO Sponsors: International Center for Neurological Restoration, Cuba; Center of Molecular Immunology, Cuba; University of Electronic Science and Technology of China Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2019 Category: Research Source Type: clinical trials